Abstract. The aim of the present study was to explore the optimal treatment strategy for patients with vertebral artery dissecting aneurysms via the endovascular approach. A total of 47 patients (50 aneurysms, including 28 ruptured and 22 unruptured) underwent endovascular treatment between January 2012 and March 2018. Of these aneurysms, 18 were treated by parent artery occlusion, 11 by stent implantation and 21 by stent-assisted coiling. The complete occlusion rate was 100% (18/18) in aneurysms treated by parent artery occlusion and 46.9% (15/32) for stent implantation with or without coiling. External drainage was performed in 8 patients with ruptured aneurysms. Post-operative bleeding occurred in 2 patients treated by stent-assisted coiling. Ventriculo-peritoneal shunt was performed in 4 patients due to delayed hydrocephalus. Post-operative frontal hematoma occurred in one patient treated by stent-assisted coiling. The mortality was 6.4% (3/47) prior to discharge. The recurrence rate was 8.3% (1/12) in aneurysms treated by parent artery occlusion and 13.6% (3/22) in those treated by stent implantation with or without coiling. A total of 39 patients were followed up for 14.56±14.91 months. The good outcome rates were 100% (28/28) in patients with unruptured aneurysms and a Hunt-Hess grade of 1-3, and 72.7% (8/11) in patients with a Hunt-Hess grade of 4 or 5. In conclusion, the present study indicated that endovascular treatment is a safe and efficient method for patients with vertebral artery aneurysm. The treatment strategy should be based on the patient's condition and aneurysmal characteristics. Parent artery occlusion may be suitable for selected patients with ruptured vertebral artery aneurysms.
Introduction
Vertebral artery dissecting aneurysm (VADA) is a rare condition accounting for 3% of intracranial aneurysms. VADA may result in subarachnoid hemorrhage and ischemic stroke (1) . However, the incidence may be underestimated due to a high rate of mortality during the early stages as a result of mortality from severe hemorrhaging. It is necessary to treat a ruptured VADA as soon as possible due to the high risk of rebleeding and mortality. Craniotomy remains a challenge for neurosurgeons. Endovascular treatment is a suitable alternative option for treating patients with VADA. It is difficult to treat VADA with a coil, and additional assistive technologies are required. The stent-assisted coiling technique extends the usage of endovascular treatment to VADA. Endovascular treatment includes destruction (parent artery occlusion) and reconstruction techniques (stent implantation with or without coiling) (2) (3) (4) (5) . However, there is currently controversy regarding the preferred treatment option. Therefore, it is necessary to determine whether endovascular treatment results in favorable outcomes in patients with VADA, and which endovascular modalities is optimal for each specific subtype of VADA. In the present study, data from 47 patients with 50 VADAs were collected and the clinical and angiographic outcomes were analyzed.
Materials and methods

Patient population.
A total of 47 patients with 50 VADAs undergoing endovascular treatment between January 2012 and March 2018 at Yijishan Hospital, Wannan Medical College (Wuhu, China) were included in the present study. Following approval from the institutional review board, the clinical and radiological materials were collected. The inclusion criterion was that VADAs were confirmed by digital subtraction angiography (DSA). The exclusion criterion was that VADAs originated from the extracranial vessel or involved the basilar artery. Hunt-Hess grading was used to evaluate the condition of the patients on admission. The clinical data are presented in Radiological characteristics. Subarachnoid hemorrhage was confirmed by CT scanning. All VADAs were confirmed by DSA with or without CTA or MRA. They were defined as dominant vertebral arteries when there was no contralateral vertebral artery or the ipsilateral vertebral artery was significantly larger compared with the contralateral one. Among the 47 cases, three patients had bilateral VADAs. The radiological characteristics of the aneurysms are presented in Table II . There were 28 ruptured aneurysms and 22 unruptured ones; furthermore, 25 aneurysms were located on the left vertebral artery and 25 on the right one. A total of 13 aneurysms were located at the dominant vertebral artery and 37 at the non-dominant vertebral artery. According to the association between the aneurysms and the posterior inferior cerebellar artery (PICA), the aneurysms were divided into three types: Proximal, distal and with involvement of the PICA. Based on this classification, 11 aneurysms were proximal to the PICA, 27 were distal to the PICA and 12 aneurysms had involvement with the PICA.
Treatment. The anti-platelet drugs (aspirin 100 mg/day and clopidogrel 75 mg/day) were administered for 3 days prior to the procedure for patients with unruptured aneurysms. All patients with ruptured aneurysms received endovascular treatment within 24 h to reduce the risk of rebleeding, except one patient who initially refused endovascular treatment. A loading dose of anti-platelet drugs (aspirin and clopidogrel, 300 mg each) was administered to patients with ruptured aneurysms who were to undergo stent deployment by oral or nasal feeding. The anti-platelet drugs (aspirin 100 mg/day and clopidogrel 75 mg/day) were administered for 6 weeks post-operatively, followed by aspirin alone.
The treatment strategy was formulated by experts according to the patients' clinical presentation, whether the aneurysm had ruptured, involvement of the dominant or non-dominant vertebral artery, and association between the aneurysms and the PICA. Parent artery occlusion was performed when the vertebral artery involved was non-dominant and the PICA was not involved. Stent implantation with or without coiling was performed in patients with unruptured aneurysms and in patients with ruptured aneurysms when the PICA was involved or the aneurysm was located on the dominant vertebral artery.
All procedures were performed under general anesthesia. A 6F sheath was placed into the right femoral artery and a 6F guiding catheter was placed into the ipsilateral vertebral artery. In certain instances, a 5F or 6F sheath was placed into the bilateral femoral artery when a bilateral vertebral artery approach was required. The stent-delivery-catheter was navigated into the basilar artery on the roadmap. A suitable stent was selected according to the length of the vessel involved. The stent should at least cover the proximal and distal part of a lesioned vessel. The diameter of a stent should be larger than that of the parent artery in order to obtain stability and adherence to the vessel. An enterprise or LVIS stent was used to reconstruct the parent artery. For patients undergoing parent artery occlusion, two micro-catheters were placed into the lesioned area in order to obtain dense embolization. For patients with bilateral aneurysms, the responsible aneurysm was estimated according to the bleeding characteristics and aneurysmal figuration. The responsible aneurysm was first treated and the other aneurysm was treated at a second stage.
Follow-up. Follow-up by DSA was scheduled to be performed 3 months after the procedure, as well as 9 and 21 months after the operation. The immediate angiographic outcomes were divided into complete occlusion and incomplete occlusion. The angiographic outcomes at follow-up were classified as follows: Complete regression (no contrast filling), incomplete regression (no change in coil configuration, obliteration grade or contrast filling) and recurrence (aneurysm recurrence evident due to aneurysm growth or coil compaction). The clinical outcomes were evaluated by using the Glasgow Outcome Scale (GOS). Favorable outcomes were defined as GOS 4 or 5 and poor outcomes were defined as GOS 1-3.
Statistical analysis. Statistical analysis was performed using SPSS for Windows v.17.0 (IBM Corp.). The Chi-squared test was used to compare the occlusion rate between parent artery occlusion and stent implantation with or without coiling. The favorable outcome rate between ruptured aneurysms and unruptured aneurysms was also compared using the chi-squared test. P<0.05 was considered to indicate a statistically significant difference.
Results
Treatment and peri-operative morbidities. The aneurysms were treated as follows: 18 were treated by parent artery occlusion, 11 by stent implantation (1 aneurysm by single LVIS, 7 by double enterprise and 3 by triple enterprise) and 21 by stent-assisted coiling (7 aneurysms by single enterprise, 12 by double enterprise and 2 by triple enterprise). There were three patients with bilateral VADAs. Of these three patients, one patient with unruptured bilateral VADAs underwent double stent implantation in stages. The second patient with ischemic stroke underwent stent-assisted coiling and another aneurysm was treated by parent artery occlusion at the second stage. For the third patient with subarachnoid hemorrhage, the major aneurysm was subjected to stent-assisted coiling and another aneurysm underwent stent-assisted coiling during the second stage. Complete occlusion was achieved in 33 aneurysms and incomplete occlusion in 17 aneurysms. All aneurysms treated by parent artery occlusion gained complete occlusion. Complete occlusion was achieved in 46.9% (15/32) of aneurysms by stent implantation with or without coiling. There was a significant difference in the complete occlusion rate between aneurysms treated by parent artery occlusion and stent implantation with or without coiling (P<0.001).
There was no evidence of intra-operative rupture in any of the procedures. Intra-operative thrombosis occurred in one patient treated by stent-assisted coiling; this patient developed symptoms of cerebellar infarction. No ischemic symptoms were observed in the patients treated by parent artery occlusion. External ventricular drainage was performed in 8 patients with ruptured aneurysms. Post-operative bleeding occurred in two patients treated by stent-assisted coiling. Post-operative frontal hematoma occurred in one patient due to a puncture. Another patient received craniotomy due to subdural hematoma. No post-operative bleeding occurred in patients treated by parent artery occlusion. Peri-operative morbidity occurred in 10.7% (3/28) of patients with a ruptured aneurysm. There was no peri-operative morbidity in patients with unruptured aneurysms (Table III) .
Ventriculo-peritoneal shunt was performed in 4 patients due to delayed hydrocephalus. Post-operative frontal hematoma occurred in one patient treated by stent-assisted coiling three days after ventriculo-peritoneal shunt, which caused an obstruction of the shunt (Fig. 1) . Ventriculo-peritoneal shunt was performed at the contralateral side.
Angiographic outcomes. In total, 31 patients (34 aneurysms) were followed up for 11.97±12.96 months (range, 3-52 months) by DSA. Of these, 4 aneurysms in 4 patients (11.8%) presented with recurrence. The recurrence rate was 8.3% (1/12) in aneurysms treated by parent artery occlusion (Fig. 2) and 13.6% (3/22) in aneurysms treated by stent implantation with or without coiling (Table IV) . In 6 patients initially treated by stent implantation, four aneurysms obtained incomplete regression and two achieved complete occlusion (Fig. 3) . Recurrence occurred in 3 of the 16 aneurysms treated by stent-assisted coiling.
Clinical outcomes. The mortality rate was 6.4% (3/47) in the patients prior to discharge (Table IV) . These deaths all occurred in patients with a Hunt-Hess grade of 5 on admission. The outcome at discharge was GOS grade 2 in 2 patients, GOS grade 3 in 5 patients, GOS grade 4 in 4 patients and GOS grade 5 in 33 patients. Favorable outcomes were achieved in 78.7% (37/47) of the entire cohort. Among the 15 patients with a Hunt-Hess grade of 4 or 5 on admission, the outcome at discharge was GOS grade 1 in 3 patients, GOS grade 2 in 2 patients, GOS grade 3 in 5 patients, GOS grade 4 in 2 patients and GOS grade 5 in 3 patients. Favorable outcomes were achieved in 64.3% (18/28) of the patients with ruptured aneurysms on admission. All 19 patients with unruptured aneurysms on admission obtained favorable outcomes. There was a significant difference in favorable outcomes between patients with ruptured aneurysms and unruptured aneurysms (P=0.003).
A total of 3 patients had died prior to discharge and 5 patients (10.6%) were lost to follow-up; the remaining 39 patients were followed up for 14.56±14.91 months (range, 3-63 months) by telephone and second admission. GOS grade 3 was obtained The complete occlusion rate after parent artery occlusion was significantly higher than that after stent placement (P<0.001). Values are expressed as n unless otherwise specified. 
Discussion
VADA usually occurs in adult patients aged 40-50 years (1). The major manifestations are subarachnoid hemorrhage and ischemic events. The diagnosis is based on CTA, MRA or DSA. DSA is currently the golden standard for the diagnosis of VADA. The rate of rebleeding and mortality is high in patients with ruptured VADA (6-9). Yamada et al (7) reported on 24 conservatively treated patients with ruptured VADA. Recurrent hemorrhage occurred in 58% of the patients and 46% of those cases died due to massive rebleeding. Timely treatment may reduce the rate of mortality and morbidity resulting from rebleeding. Therefore, the majority of the patients in the present study underwent endovascular treatment during the first 24 h. The treatment for patients with an unruptured VADA remains controversial. According to certain clinicians, conservative treatment may achieve good outcomes (9). Guan et al (10) suggested that patients with enlarged VADA aneurysms and those with progressive ischemia following medical treatment should be treated using an endovascular approach. Naito et al (11) indicated that patients with VADA with relatively large or growing dilations should receive endovascular treatment. An unruptured VADA should be treated due to a higher mortality rate following rupture, particularly for aneurysms with irregular figuration or morphological changes, multiple aneurysms or when combined with hypertension.
The primary treatment strategy consists of surgery and endovascular embolization. Ligation of the lesioned artery and blood reconstruction may be performed by surgery (vertebral artery or occipital artery-PICA bypass) (12, 13) . However, it may be difficult to perform surgical treatment due to a deep location, adjacent brain stem and posterior cranial nerves. Endovascular embolization is the preferred strategy for VADA due to its safety and efficiency, which includes reconstruction and destruction techniques (1, 14) . Destruction technique refers to parent artery occlusion. The reconstruction technique consists of stent implantation with or without coiling and flow-diverting stent.
The destruction technique is the most effective method to prevent aneurysm rupture and rebleeding (2, 3) . The immediate obliteration rate is high. The obliteration rate was 100% in the patients included in the present study, which was similar to that in other studies. Madaelil et al (3) reported on 12 patients with VADA involving distal vertebral artery (n=10) or PICA (n=2) treated by parent artery occlusion. Only one patient suffered from ischemic stroke and one patient died prior to discharge. There was no recurrence at follow-up and 10 patients (83%) achieved favorable outcomes. A meta-analysis by Guan et al (10) demonstrated that the immediate obliteration rate was higher in patients treated with parent artery occlusion compared with that in patients treated with stent-assisted coiling. However, there was no significant difference in clinical outcomes and recurrence rate between them in the long-term follow-up. The efficacy of parent artery occlusion comes at the expense of a lesioned vertebral artery. Parent artery occlusion may result in severe complications when the lesioned artery is dominant compared with the contralateral side or if the PICA is involved. Parent artery occlusion should be performed when the basilar artery and the PICA are able to maintain a sufficient blood supply (15) . There was no evidence of brain infarction in the 18 patients treated by parent artery occlusion in the present study. The rate of favorable outcome for patients with ruptured aneurysms in the present study was 64.3%, which appeared to be worse than that reported in previous studies (5, 16) . However, this may be due to high Hunt-Hess grades in the cohort of the present study. Patients with a Hunt-Hess grade of 4 or 5 accounted for 53.6% (15/28) of cases with ruptured aneurysms.
The aim of stent implantation with or without coiling is to keep the vertebral artery unobstructed and reduce the pressure of blood flow on the vessel wall by maintaining the flow direction. The coil facilitates the repair of dissection by thrombosis. Multiple stents may increase the metal coverage. Zhao et al (5) reported on 57 patients with VADA treated by stent-assisted coiling. The peri-operative morbidity rate was 5% (3/57) and the overall mortality rate was 5% (3/57). After an average of 27 months of angiographic follow-up, 42 of the 54 patients obtained complete occlusion, 7 exhibited improved results and 5 experienced recurrence. They indicated that immediate incomplete occlusion was an independent risk factor for recurrence. After a mean follow-up of 62 months, 47 patients obtained favorable outcomes (mRS, 0-1), and high age (56.90±10.88 years) and worse Hun-Hess grading were associated with poor outcome (5). Chung et al (4) reported on 8 patients with 9 VADAs (including 1 ruptured and 8 unruptured) treated with triple stent implantation. A total of 8 unruptured VADAs returned to normal after 3 months of angiographic follow-up and 1 patient suffered from recurrence and received double stent implantation. Finally, 7 patients obtained favorable outcomes after a median clinical follow-up of 22.6 months. Flow-diversion, including pipeline embolization device, has higher metal coverage. An increasing number of studies have been reporting on the use of flow-diversion in the treatment of VADA. Narata et al (15) suggested that flow-diversion modifies aneurysmal hemodynamics and accelerates thrombosis.
However, the use of stents may increase the risk of an ischemic event during the acute phase (16) . The use of anti-platelet drugs may increase the rate of rebleeding, particularly in patients with an incomplete occlusion. It may result in post-operative hematoma due to puncture, particularly in patients with acute hydrocephalus requiring external drainage. In the present study, 8 patients received external ventricular drainage. Although heparin was neutralized by protamine, one patient exhibited subdural hematoma and another patient suffered from frontal hematoma due to puncture. All hematoma occurred in patients treated with stent-assisted coiling. Ventriculo-peritoneal shunt was performed in 4 patients due to delayed hydrocephalus. Post-operative frontal hematoma occurred in one patient treated with stent-assisted coiling three days after shunting. Ventriculo-peritoneal shunt was performed on the contralateral side.
There are certain limitations to the present study. It was a retrospective and non-randomized study. The number of patients and duration of follow-up were also limited. Certain patients were lost to follow-up due to unfavorable outcomes or loss of contact information.
In conclusion, endovascular treatment of VADA is an effective and safe method. Stent implantation with or without coiling is suitable for unruptured VADA, PICA involvement and dominant vertebral artery. In cases with a ruptured VADA, parent artery occlusion may be preferred, as the obliteration rate is higher. It may decrease the probability of post-operative rebleeding and reduce the requirement for anti-platelet drugs, which increases the probability of post-operative rebleeding, particularly in patients with acute hydrocephalus requiring external drainage.
